Skip to main content

Articles

Practice Management
Disruptive Innovation: Value-Based Health Plans
Stakeholder Perspective
Value-Based Drug Benefit: Implications for Manufacturers
Read More
Practice Management
Role of NCCN in Integrating Cancer Clinical Practice Guidelines into the Healthcare Debate
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
Original Research
Measuring the Value of Treatment to Patients: Patient-Reported Outcomes in Drug Development
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
FDA Approvals
Approvable Letters in 2007 and the Outlook for 2008
Read More
Practice Management
The 2007 Pharmaceutical and Biotech Pipeline Year-End Summary: What it Says About the State of the Art of Discovery & Development
Read More
Perspectives
Contracting for Compliance: Using Adherence as a Patient-Centered Measure of Performance
Read More
Practice Management
Wayward Prescriptions: Costs of Fraud in Payor Plans
Stakeholder Perspective
Procedures Needed to Prevent Prescription Fraud
Read More
Bustling Pipeline for Diabetes and Its Metabolic Consequences
Read More
Practice Management
FDA Bolsters Its Generic Approval Process: Health Plans Reap the Benefits
Read More
FDA Approvals
Heparin at the Center of the Storm
Read More
Page 233 of 244
Results 2321 - 2330 of 2436